USPTO serial 79401325
AMYLO
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Oct 14, 2025
- Examiner
- FICKES, JERI J
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with AMYLO?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
April L. Besl
April L. Besl Dinsmore & Shohl LLP255 East Fifth StreetSuite 1900Cincinnati, OH 45202Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Software as a medical device (SaMD), downloadable, for treating Alzheimer's disease; downloadable computer software for data processing in the field of Alzheimer's disease; downloadable computer software for database management in the field of Alzheimer's disease; downloadable software for processing digital images in the field of Alzheimer's disease; downloadable software for processing images, graphics and text in the field of Alzheimer's disease; downloadable computer software for diagnosing diseases, namely, Alzheimer's disease, for medical purposes; downloadable computer software for use in medical decision support systems in the field of Alzheimer's disease; data processing apparatus for use in the field of Alzheimer's disease; downloadable image files of human brains for use in the field of Alzheimer's disease; downloadable electronic documents in the field of image processing for use in treatment of Alzheimer's disease | ACTIVE | — |
| 010 | Medical apparatus for the diagnosis of cerebrovascular diseases; medical apparatus for the diagnosis of neurological diseases; medical apparatus and instruments for predicting, diagnosing, and treating Alzheimer's disease; apparatus for carrying-out diagnostic tests for Alzheimer's disease for medical purposes; diagnostic apparatus for diagnosing Alzheimer's disease for medical purposes; radiological diagnostic imaging apparatus, namely, Positron Emission Tomography (PET), Computed Tomography (CT), and Magnetic Resonance Imager (MRI) for medical purposes relating to diagnosis and treatment of Alzheimer's disease; diagnostic measuring apparatus for medical use for measuring beta-amyloid plaque for use in the diagnosis and tratment of Alzheimer's disease; medical apparatus and instruments, namely, apparatus for medical diagnostic testing for use in the fields of clinical diagnosis of Alzheimer's disease; automatic analyzers in the nature of PET, CT, and MRI for medical diagnosis of Alzheimer's disease; electromedical diagnostic instruments for diagnosing Alzheimer's disease | ACTIVE | — |
| 042 | Software as a service (SAAS) services featuring software for image processing for use in diagnosis and treatment of Alzheimer's disease; technological and scientific remote monitoring services relating to the function of medical diagnostic devices in the field of Alzheimer's disease; research and development of medical apparatus and instruments for use in Alzheimer's disease medical diagnostic testing for others; research and development of medical equipment for use in Alzheimer's disease medical diagnostic testing; research and development of medical devices for use in Alzheimer's disease medical diagnostic testing; providing technological support services, namely, providing technical advice related to the research and development of medical diagnostic instruments for use in diagnosing Alzheimer's disease; technological and scientific monitoring services relating to the function of Alzheimer's disease medical diagnostic instruments; technology consultation in the field of artificial intelligence for use in the field of diagnosing and treating Alzheimer's disease; research and development of diagnostic apparatus for use in diagnosing Alzheimer's disease; computer aided diagnostic testing services for use in diagnosing Alzheimer's disease | ACTIVE | — |
| 044 | Providing medical advice in the field of geriatrics relating to Alzheimer's disease; medical analysis for the diagnosis and treatment of persons with Alzheimer's disease; health care services for treating Alzheimer's disease; remote monitoring of medical data for medical diagnosis and treatment of Alzheimer's disease; medical analysis services for the diagnosis of Alzheimer's disease; medical diagnostic services for Alzheimer's disease; mental health screening services relating to Alzheimer's disease; medical testing services relating to the diagnosis and treatment of Alzheimer's disease; performing diagnosis of Alzheimer's disease; medical advisory services relating to the treatment of degenerative diseases, namely, Alzheimer's disease | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by BeauBrain Healthcare
- Other trademarks owned by BeauBrain Healthcare
- Other trademarks owned by BeauBrain Healthcare
- Other trademarks in Class 009
- Other trademarks in Class 010
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named AMYLO
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| May 14, 2026 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Apr 28, 2026 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Apr 28, 2026 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Jan 15, 2026 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Jan 14, 2026 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Dec 31, 2025 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Dec 31, 2025 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Oct 14, 2025 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Oct 14, 2025 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Aug 26, 2025 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Aug 26, 2025 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Aug 20, 2025 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jul 18, 2025 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jul 18, 2025 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jul 18, 2025 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jul 18, 2025 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jul 18, 2025 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jun 27, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 27, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 27, 2025 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 17, 2025 | RFNT | REFUSAL PROCESSED BY IB | — |
| Dec 27, 2024 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Dec 27, 2024 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Dec 13, 2024 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Dec 12, 2024 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 12, 2024 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 6, 2024 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Aug 6, 2024 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Aug 1, 2024 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |